PI3k inhibitors in NHL and CLL: an unfulfilled promise
N Bou Zeid, V Yazbeck - Blood and Lymphatic Cancer: Targets and …, 2023 - Taylor & Francis
Abstract Phosphatidylinositol 3-kinases (PI3Ks) are a family of intracellular signal transducer
enzymes that can attach a phosphate group to the 3'-hydroxyl of the inositol moiety of …
enzymes that can attach a phosphate group to the 3'-hydroxyl of the inositol moiety of …
[HTML][HTML] 13q14 deletion and its effect on prognosis of chronic lymphocytic leukemia
K Khalid, J Padda, M Syam, A Moosa, V Kakani… - Cureus, 2021 - ncbi.nlm.nih.gov
Chronic lymphocytic leukemia (CLL) is the most common leukemia affecting adults. CLL
results due to uncontrolled accumulation of B lymphocytes in the body with the clinical …
results due to uncontrolled accumulation of B lymphocytes in the body with the clinical …
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model
X Zhang, Y Han, X Hu, H Wang, Z Tian, Y Zhang… - Biomarker …, 2022 - Springer
Background Chronic lymphocytic leukemia (CLL) is a heterogeneous B-cell malignancy that
lacks specific biomarkers and drug targets. Competing endogenous RNAs (ceRNAs) play …
lacks specific biomarkers and drug targets. Competing endogenous RNAs (ceRNAs) play …
StellarPath: Hierarchical-vertical multi-omics classifier synergizes stable markers and interpretable similarity networks for patient profiling
The Patient Similarity Network paradigm implies modeling the similarity between patients
based on specific data. The similarity can summarize patients' relationships from high …
based on specific data. The similarity can summarize patients' relationships from high …
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories
G Gkoliou, A Agathangelidis, G Karakatsoulis… - Frontiers in …, 2023 - frontiersin.org
The analysis of the immunogenetic background of multiple myeloma (MM) has proven key to
understanding disease ontogeny. However, limited information is available regarding the …
understanding disease ontogeny. However, limited information is available regarding the …
Dysregulation of small nucleolar RNAs in B-cell malignancies
MWC Verbeek, SJ Erkeland, VHJ van der Velden - Biomedicines, 2022 - mdpi.com
Small nucleolar RNAs (snoRNAs) are responsible for post-transcriptional modification of
ribosomal RNAs, transfer RNAs and small nuclear RNAs, and thereby have important …
ribosomal RNAs, transfer RNAs and small nuclear RNAs, and thereby have important …
Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia
JCL da Silva, F Saldanha-Araujo, RCB de Melo… - Life Sciences, 2022 - Elsevier
Aims Despite the development of therapeutic strategies for chronic lymphocytic leukemia
(CLL), most patients remain incurable, relapse, or refractory to current treatments, indicating …
(CLL), most patients remain incurable, relapse, or refractory to current treatments, indicating …
GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms
AÉ Silva-Carvalho, LDC Filiú-Braga, GMR Bogéa… - Cancer Cell …, 2024 - Springer
Histone methyltransferases (HMTs) are enzymes that regulate histone methylation and play
an important role in controlling transcription by altering the chromatin structure. Aberrant …
an important role in controlling transcription by altering the chromatin structure. Aberrant …
Combined Delivery of miR-15/16 through Humanized Ferritin Nanocages for the Treatment of Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is a widespread type of leukemia that predominantly
targets B lymphocytes, undermining the balance between cell proliferation and apoptosis. In …
targets B lymphocytes, undermining the balance between cell proliferation and apoptosis. In …
[HTML][HTML] Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations
P Liu, K Wang, J Li, MA Ogasawara, Z Xia… - …, 2024 - ncbi.nlm.nih.gov
It has been known for decades that the incidence of chronic lymphocytic leukemia (CLL) is
significantly lower in Asia than in Western countries, but the reason responsible for this …
significantly lower in Asia than in Western countries, but the reason responsible for this …